Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, ...
Hyderabad: Universities campuses turn hotbeds of unrest
From PJTAU, BRAOU, UoH to OU, the varsities that are supposed to be hubs for academics and research turned into site of ...
生物通1 天
3D 生物功能磁性支架：骨再生治疗的新希望
为了给骨组织工程带来新的突破，来自西班牙马德里康普顿斯大学、意大利比萨大学等机构的研究人员展开了一项极具意义的研究。他们成功制备出了 3D 生物功能磁性支架，并将相关研究成果发表在了《Tissue Engineering and Regenerative Medicine》杂志上。
Can-Fite BioPharma Ltd.: Can-Fite to Initiate Phase II Study in the Rare Genetic Disease ...
FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE Am ...
Medscape2 天
Pediatric Urinary Tract Infections
Urinary tract infection (UTI) is the most common serious bacterial infection in childhood. Prompt diagnosis and treatment are required for the optimal clinical outcome and the prevention of long ...
生物通28 天
综述：揭秘五种重金属中毒临床治疗新进展：打破困境，探寻希望之路
他们经过深入研究得出结论：螯合疗法（使用特定化合物与重金属结合，帮助排出体外的治疗方法）是治疗重金属中毒很有前景的方法，像二巯基丁二酸（DMSA）和二巯基丙磺酸钠（DMPS）等新型螯合剂副作用较小，正逐渐被临床毒理学家认可。不过，目前汞中毒 ...